Research article · 27 Jan 2021
Conference abstractPublished 6 Jun 2016
Cardiovascular Disease (CVD) and Diabetes-Know Your Risk-Is it time for a paradigm shift
University of Nevada, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cardiovascular Disease is a major complication of diabetes and the leading cause of early death among people with diabetes about 65 percent of people with diabetes die from heart disease and stroke. Annually in the United States 1,000,000 people will suffer a myocardial infarction: One-third of those will occur in people who have already suffered an event. Modification of traditional risk factors, such as smoking cessation, decreasing blood pressure and lowering of cholesterol in high risk individuals has resulted in reducing CVD and stroke remarkably. However, the current standard of care using traditional modifiable risk factors alone is frequently inadequate to identify some individuals with CVD. Therefore, it is important to not rely solely on risk factor modification when assessing for CVD, but also to incorporate a disease platform. A new paradigm focusing on the disease (atherosclerosis) is necessary. Non-invasive endothelial testing [coronary calcium score (CCS), carotid intima media thickness (cIMT)], genetics assessment [Apolipoprotein E (ApoE), kinesin-like protein 6 (KIF6), 9 region p21 locus (9p21), lipoprotein (a) (LPA) and haptoglobin genotype (Hp 1-1, Hp 1-2, Hp 2-2)] and measurement of major biomarkers [F2-Isoprostanes (F2-IsoPs), high sensitivity C-reactive protein (hs-CRP), urine albumin creatinine ratio (UACR), myeloperoxidase (MPO), lipoprotein associated phospholipase A2 (Lp-PLA2), fibrinogen, and homocysteine (Hcy)] enhance the ability to identify disease (atherosclerosis) earlier. When disease is found, the causes must be identified and treated. A paradigm shift focusing on arteriology (disease platform) is mandated to reduce the high rate of recurrence of CVD and stroke.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 2017
Lower Cardiovascular Risk with Diabetic Drugs: A Paradigm Shift from Glucocentricity to Cardio Protectiveness
Other · Jul 2015
Diabetes drug development: time for a shift in paradigm
Conference abstract · 15 Sep 2016
Phenotype of paraoxonase 1, oxidative stress biomarkers and the risk of cardiovascular diseases development in healthy, diabetic, and hemodialysis patients
Conference abstract · 1 Sep 2015
Oxidative stress biomarkers measurements, particularly Paraoxonase 1 phenotype distribution is associated with cardiovascular diseases risk in healthy, diabetic and hemodialysis patients
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectCardiology
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Claude K Lardinois”
